BAM Wealth Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$511K Sell
4,629
-1,546
-25% -$149K 0.28% 93
2026
Q2
$483K Buy
6,175
+1,691
+38% +$115K 0.3% 85
2026
Q1
$290K Buy
+4,484
New +$316K 0.22% 117

Other funds holding HALO

BAM Wealth Management's HALO Position: Q3 2026 in Review

BAM Wealth Management reduced its Halozyme (HALO) stake by 25% in Q3 2026, selling an estimated $149K and leaving 4,629 shares worth $511K. The position accounts for 0.28% of the portfolio, ranked #93.

BAM Wealth Management first reported a position in HALO in Q1 2026 and has held it in 3 quarters since. 412 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • BAM Wealth Management held 4,629 shares of Halozyme worth $511K as of Q3 2026.
  • BAM Wealth Management sold 1,546 Halozyme shares in Q3 2026, an estimated $149K.
  • Halozyme made up 0.28% of BAM Wealth Management's portfolio in Q3 2026, its #93 holding.
  • BAM Wealth Management first reported a position in Halozyme in Q1 2026 and has held it in 3 quarters since.
  • 412 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on BAM Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.